1 |
Kocsmár É, Kocsmár I, Szalai L, Lendvai G, Szijártó A, Schaff Z, Kiss A, Kovalszky I, Papp G, Lotz G. Cross-testing of major molecular markers indicates distinct pathways of tumorigenesis in gastric adenocarcinomas and synchronous gastrointestinal stromal tumors. Sci Rep 2020;10:22212. [PMID: 33335133 DOI: 10.1038/s41598-020-78232-2] [Reference Citation Analysis]
|
2 |
Waidhauser J, Bornemann A, Trepel M, Märkl B. Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia. World J Gastroenterol 2019; 25(30): 4261-4277 [PMID: 31435178 DOI: 10.3748/wjg.v25.i30.4261] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
3 |
Koçer M, Muallaoğlu S, Çetin B, Coşkun HŞ, Karahan N, Gürdal O. Second Primary Tumors in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience. Medicina (Kaunas) 2021;57:494. [PMID: 34068309 DOI: 10.3390/medicina57050494] [Reference Citation Analysis]
|
4 |
Mayr P, Märkl B, Agaimy A, Kriening B, Dintner S, Schenkirsch G, Schneider-Stock R. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA. Langenbecks Arch Surg 2019;404:605-13. [PMID: 30877378 DOI: 10.1007/s00423-019-01773-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
5 |
Fernández JA, Olivares V, Gómez-Ruiz AJ, Ferri B, Frutos MD, Soria T, Torres G, Parrilla P. Additional malignancies in patients with gastrointestinal stromal tumors (GIST): incidence, pathology and prognosis according to a time of occurrence-based classification. Clin Transl Oncol 2019;21:646-55. [PMID: 30368726 DOI: 10.1007/s12094-018-1966-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|